Managing cardiometabolic health in patients with a history of cancer is increasingly important. Discover the primary considerations including impact of demographic variables, cancer types, and treatment modalities.
Pediatric low-grade gliomas often cause long-term morbidities despite high overall survival rates. But advances in molecular characterization, targeted therapies, and surgical techniques are improving management and outcomes.
This case serves as a prompt to consider the possibility of cryptococcosis, even when lung cancer has already been diagnosed, when lung radiology shows multiple nodules.
The amelanotic variant of conjunctival malignant melanoma is extremely rare and can be difficult to diagnose. But clinicians must be vigilant when changes in the conjunctiva and eyelids are noticed.
This case serves as a prompt to consider the possibility of cryptococcosis, even when lung cancer has already been diagnosed, when lung radiology shows multiple nodules.
The amelanotic variant of conjunctival malignant melanoma is extremely rare and can be difficult to diagnose. But clinicians must be vigilant when changes in the conjunctiva and eyelids are noticed.
Thyroid ablation technology has developed rapidly in the past 20 years, but these two cases highlight how incomplete ablation of thyroid nodules hinders its use as a treatment for thyroid cancer.
How do nutrition, supplements and antibiotics impact patient outcomes?
Recent research suggests that the gut microbiome could be an important modulator of response to CAR T-cell therapy in patients with hematologic cancers.
Prof. Marion Subklewe takes us through the latest evidence, highlighting the impact of antibiotics, nutrition, and dietary supplements, and discusses how to devise interventions to improve patient outcomes.
The application of artificial intelligence (AI) in lung cancer, particularly in surgical approaches, has significantly transformed the healthcare landscape. AI has demonstrated remarkable advancements in early lung cancer detection, precise …
VEXAS (vacuoles, E1 enzyme, X-linked, autoinflammatory, somatic) syndrome is a rare adult-onset progressive autoinflammatory condition recently characterized by the NIH in 2020 [ 1 ]. UBA1 encodes for the main E1-activating enzyme that is …
The complex relationship between natural killer (NK) cells and dendritic cells (DCs) within the tumor microenvironment significantly impacts the success of cancer immunotherapy. Recent advancements in cancer treatment have sought to bolster innate …
Non-small cell lung cancer is the most common cause of cancer death globally. When apparent incidental pathogenic germline variants (PGVs) are uncovered with routine next generation sequencing (NGS) of NSCLCs, germline testing (GT) is recommended …
Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.
A series of patient cases underpin this interactive webinar that aims to provide practical guidance on a multidisciplinary approach to managing patients with cutaneous T-cell lymphoma.
An independent symposium at the 10th COMy World Congress focusing on BCMA-targeting strategies for the treatment of multiple myeloma. Gain insights into the latest clinical data and the implications for clinical practice.
The evolving landscape of metastatic urothelial carcinoma brings with it many challenges, such as optimally sequencing therapies and managing adverse events. Navigate your way through these with the Ultimate mUC challenge game and expert-to-expert interviews.
Supported by:
Merck Healthcare KGaA, Darmstadt, Germany and Astellas
Surgical resection constitutes a major curative-intent treatment option for resectable hepatocellular carcinoma (HCC) [ 1 ]. One of the main challenges in the surgical planning of HCC is to determine the appropriate resection margin to ensure …
Immunotherapy improves survival outcomes in cancer patients, but there is still an unmet clinical need in the treatment of brain metastases. Here, we used a mouse model to investigate the antitumor effect of programmed death-ligand 1 (PD-L1) and …
Liver cancer is the fifth most common form of cancer and the fourth leading cause of cancer-related death. The most frequent tumor type is hepatocellular carcinoma (HCC), which accounts for more than 80% of primary liver cancer events worldwide [ 1 …]. It is projected that by the year 2040, an estimated 1.3 million people could die from liver cancer, representing a 56.4% increase compared to the figures reported in 2020 [
Breast cancer accounts for 20–30% of all cancer cases in women and is the most often diagnosed malignancy in females [ 1 ]. Its subtype, called triple-negative breast cancer (TNBC), is characterized by the lack of human epidermal growth factor …
In four patients with chronic myeloid leukemia and a history of bariatric surgery, TKI concentrations were found to be subtherapeutic, and all needed TKI switches and/or dose modifications to achieve a response.
Pediatric low-grade gliomas often cause long-term morbidities despite high overall survival rates. But advances in molecular characterization, targeted therapies, and surgical techniques are improving management and outcomes.
